The Korean journal of internal medicine

  • 제30권4호
  • /
  • Pages.506-514
  • /
  • 2015
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Infections after lung transplantation: time of occurrence, sites, and microbiologic etiologies

  • Yun, Ji Hyun (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sang-Oh (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jo, Kyung-Wook (Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Se Hoon (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Jina (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chae, Eun Jin (Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Do, Kyung-Hyun (Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Dae-Kee (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, In-Cheol (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hong, Sang-Bum (Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shim, Tae Sun (Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Hyeong Ryul (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Dong Kwan (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2014.12.26
  • 심사 : 2015.03.30
  • 발행 : 2015.07.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: Infections are major causes of both early and late death after lung transplantation (LT). The development of prophylaxis strategies has altered the epidemiology of post-LT infections; however, recent epidemiological data are limited. We evaluated infections after LT at our institution by time of occurrence, site of infections, and microbiologic etiologies. Methods: All consecutive patients undergoing lung or heart-lung transplantation between October 2008 and August 2014 at our institution were enrolled. Cases of infections after LT were initially identified from the prospective registry database, which was followed by a detailed review of the patients' medical records. Results: A total of 108 episodes of post-LT infections (56 bacterial, 43 viral, and nine fungal infections) were observed in 34 LT recipients. Within 1 month after LT, the most common bacterial infections were catheter-related bloodstream infections (42%). Pneumonia was the most common site of bacterial infection in the 2- to 6-month period (28%) and after 6 months (47%). Cytomegalovirus was the most common viral infection within 1 month (75%) and in the 2- to 6-month period (80%). Respiratory viruses were the most common viruses after 6 months (48%). Catheter-related candidemia was the most common fungal infection. Invasive pulmonary aspergillosis developed after 6 months. Survival rates at the first and third years were 79% and 73%, respectively. Conclusions: Although this study was performed in a single center, we provide valuable and recent detailed epidemiology data for post-LT infections. A further multicenter study is required to properly evaluate the epidemiology of post-LT infections in Korea.

키워드

참고문헌

  1. Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report: 2014; focus theme: retransplantation. J Heart Lung Transplant 2014;33:1009-1024. https://doi.org/10.1016/j.healun.2014.08.004
  2. Korean Network for Organ Sharing. National data for organ transplantation [Internet]. Seoul (KR): Korean Net-work for Organ Sharing, c2014 [cited 2014 Dec 1]. Available from: http://www.konos.go.kr/konosis/sub4/sub04_03_01_pop.jsp.
  3. de Perrot M, Chaparro C, McRae K, et al. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004;127:1493-1501. https://doi.org/10.1016/j.jtcvs.2003.11.047
  4. Zander DS, Baz MA, Visner GA, et al. Analysis of early deaths after isolated lung transplantation. Chest 2001;120:225-232. https://doi.org/10.1378/chest.120.1.225
  5. Kanj SS, Tapson V, Davis RD, Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997;112:924-930. https://doi.org/10.1378/chest.112.4.924
  6. Maurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest 1992;101:1056-1059. https://doi.org/10.1378/chest.101.4.1056
  7. Parada MT, Alba A, Sepulveda C. Early and late infections in lung transplantation patients. Transplant Proc 2010;42:333-335. https://doi.org/10.1016/j.transproceed.2009.12.002
  8. Humar A, Michaels M; AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006;6:262-274. https://doi.org/10.1111/j.1600-6143.2005.01207.x
  9. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004;140:18-25. https://doi.org/10.7326/0003-4819-140-1-200401060-00007
  10. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26:1229-1242. https://doi.org/10.1016/j.healun.2007.10.017
  11. Kim SY, Shin JA, Cho EN, et al. Late respiratory infection after lung transplantation. Tuberc Respir Dis (Seoul) 2013;74:63-69. https://doi.org/10.4046/trd.2013.74.2.63
  12. Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008;178:363-371. https://doi.org/10.1164/rccm.200712-1834OC
  13. Avery RK. Infections after lung transplantation. Semin Respir Crit Care Med 2006;27:544-551. https://doi.org/10.1055/s-2006-954612
  14. Palmer SM, Limaye AP, Banks M, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med 2010;152:761-769. https://doi.org/10.7326/0003-4819-152-12-201006150-00003
  15. Razonable RR, Humar A; AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:93-106. https://doi.org/10.1111/ajt.12103
  16. Chang YS, Kim Y, Kim DY, et al. Two cases of post transplant lymphoproliferative disorder in lung transplant recipients. Korean J Intern Med 2004;19:276-281. https://doi.org/10.3904/kjim.2004.19.4.276
  17. Paik HC, Hwang JJ, Kim DH, Joung EK, Kim HK, Lee DY. The 10 years experience of lung transplantation. Korean J Thorac Cardiovasc Surg 2006;39:822-827.
  18. Allen UD, Preiksaitis JK; AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:107-120. https://doi.org/10.1111/ajt.12104
  19. Minari A, Husni R, Avery RK, et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002;4:195-200. https://doi.org/10.1034/j.1399-3062.2002.t01-2-02002.x

피인용 문헌

  1. Sterilization of Lung Matrices by Supercritical Carbon Dioxide vol.22, pp.3, 2015, https://doi.org/10.1089/ten.tec.2015.0449
  2. Voriconazole-refractory invasive aspergillosis vol.32, pp.5, 2015, https://doi.org/10.3904/kjim.2017.109
  3. Pattern and Predictors of Hospital Readmission During the First Year After Lung Transplantation vol.17, pp.5, 2015, https://doi.org/10.1111/ajt.14064
  4. The First Living-Donor Lobar Lung Transplantation in Korea: a Case Report vol.33, pp.43, 2015, https://doi.org/10.3346/jkms.2018.33.e282
  5. Retransplantation Outcomes at a Large Lung Transplantation Program vol.4, pp.11, 2018, https://doi.org/10.1097/txd.0000000000000844
  6. WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis vol.50, pp.10, 2015, https://doi.org/10.1016/j.transproceed.2018.08.018
  7. Microbiological findings in bronchoalveolar lavage fluid from lung transplant patients in Sweden vol.20, pp.6, 2015, https://doi.org/10.1111/tid.12973
  8. Multidrug-resistant Acinetobacter baumannii infection in lung transplant recipients: risk factors and prognosis vol.51, pp.7, 2015, https://doi.org/10.1080/23744235.2018.1556400
  9. Infectious complications of bronchial stenosis in lung transplant recipients vol.21, pp.4, 2015, https://doi.org/10.1111/tid.13100
  10. Imaging Evaluation of Lung Transplantation Patients : A Time and Etiology-based Approach to High-resolution Computed Tomography Interpretation vol.34, pp.5, 2015, https://doi.org/10.1097/rti.0000000000000419
  11. Long-Term Outcomes of Adult Lung Transplantation Recipients: A Single-Center Experience in South Korea vol.82, pp.4, 2015, https://doi.org/10.4046/trd.2019.0016
  12. Infections in Lung Transplant Recipients during and after Prophylaxis vol.52, pp.4, 2020, https://doi.org/10.3947/ic.2020.52.4.600
  13. The Etiology and Prognosis of Delayed Postoperative Leukocytosis in Lung Transplant Recipients vol.30, pp.2, 2015, https://doi.org/10.1177/1526924820913516
  14. A Retrospective Cohort Study of Risk Factors for Surgical Site Infection Following Lung Transplant vol.30, pp.4, 2015, https://doi.org/10.1177/1526924820958133
  15. Nebulized Amphotericin B Dosing Regimen for Aspergillus Prevention After Lung Transplant vol.19, pp.1, 2015, https://doi.org/10.6002/ect.2020.0187
  16. Successful Lobar Lung Transplant From a Marginal Deceased Donor With a History of Treated Pulmonary Tuberculosis: A Case Report vol.19, pp.3, 2015, https://doi.org/10.6002/ect.2020.0501